Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
NCT ID: NCT06588296
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
279 participants
INTERVENTIONAL
2024-09-24
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participation in this study includes up to 12 visits and could last up to 61 weeks including screening, open label treatment period, and post-treatment follow-up period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
NCT06588283
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
NCT06864026
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
NCT06857942
A Study of Ixekizumab in Participants With Active Psoriatic Arthritis
NCT01695239
A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
NCT02584855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ixekizumab
Ixekizumab administered subcutaneous (SC).
Ixekizumab
Administered SC
Ixekizumab and Tirzepatide
Ixekizumab concomitantly administered with tirzepatide SC.
Ixekizumab
Administered SC
Tirzepatide
Administered SC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ixekizumab
Administered SC
Tirzepatide
Administered SC
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have active PsA, defined as the presence of at least 3 of 68 tender joints and at least 3 of 66 swollen joints.
* Have obesity, body mass index of ≥30 kilograms per meter squared (BMI ≥30 kg/m²) or overweight (BMI ≥27 to \<30 kg/m²) in the presence of at least 1 of these weight-related comorbid conditions (hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or T2DM).
Exclusion Criteria
* Have Type 1 Diabetes Mellitus (T1DM).
* Have insulin-treated Type 2 Diabetes Mellitus (T2DM).
* Have a prior or planned surgical treatment for obesity.
* Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia (MEN) syndrome type 2.
* Have active, or a history of inflammatory bowel disease (Crohn's or ulcerative colitis).
* Have a diagnosis or history of malignant disease within the 5 years prior to randomization, with the following exceptions:
* basal cell or squamous epithelial carcinomas of the skin that have been resected, with no evidence of metastatic disease for 3 years.
* cervical carcinoma in situ, with no evidence of recurrence within the 5 years prior to randomization.
* Have a serious disorder or illness other than PsA.
* Have a history of chronic or acute pancreatitis.
* Have any prior use of ixekizumab or tirzepatide.
* Diagnosis of other inflammatory arthritis, such as Rheumatoid Arthritis (RA), ankylosing spondylitis, reactive arthritis, gout, or enteropathic arthritis.
* Have a previous failure or intolerance to an interleukin 17 inhibitor (IL-17i) or glucagon-like peptide 1 (GLP-1) receptor agonists.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Role: STUDY_DIRECTOR
Eli Lilly and Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale
Avondale, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler
Chandler, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff
Flagstaff, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Gilbert
Gilbert, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale
Glendale, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Mesa
Mesa, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Phoenix PV
Phoenix, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Sun City
Sun City, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson
Tucson, Arizona, United States
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson Southeast
Tucson, Arizona, United States
Medvin Clinical Research - Apple Valley
Apple Valley, California, United States
Medvin Clinical Research - Covina
Covina, California, United States
Newport Huntington Medical Group
Huntington Beach, California, United States
Purushotham & Akther Kotha MD, Inc
La Mesa, California, United States
Medvin Clinical Research - Riverside
Riverside, California, United States
Rheumatology Center of San Diego
San Diego, California, United States
Medvin Clinical Research - Temecula
Temecula, California, United States
Cohen Medical Centers
Thousand Oaks, California, United States
Medvin Clinical Research - Tujunga
Tujunga, California, United States
Medvin Clinical Research - Whittier
Whittier, California, United States
Denver Arthritis Clinic
Denver, Colorado, United States
Clinical Research of West Florida, Inc. (Clearwater)
Clearwater, Florida, United States
NeoClinical Research
Hialeah, Florida, United States
South Florida Rheumatology
Hollywood, Florida, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Vida Clinical Research
Kissimmee, Florida, United States
Life Clinical Trials
Margate, Florida, United States
Suncoast Clinical Research, Inc.
New Port Richey, Florida, United States
Vitalia Medical Research
Palm Beach Gardens, Florida, United States
Sarasota Arthritis Center
Sarasota, Florida, United States
Clinical Research of West Florida
Tampa, Florida, United States
International Center for Research
Tampa, Florida, United States
Conquest Research
Winter Park, Florida, United States
Southeastern Rheumatology Alliance dba Arthritis Center of North Georgia
Gainesville, Georgia, United States
Atlanta Research Center for Rheumatology
Marietta, Georgia, United States
St. Luke's Clinic
Boise, Idaho, United States
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, United States
Greater Chicago Specialty Physicians
Schaumburg, Illinois, United States
Arnold Arthritis & Rheumatology
Skokie, Illinois, United States
Willow Rheumatology and Wellness PLLC
Willowbrook, Illinois, United States
Qualmedica Research, LLC
Evansville, Indiana, United States
Alliance for Multispecialty Research, LLC
Wichita, Kansas, United States
Accurate Clinical Research, Inc
Lake Charles, Louisiana, United States
Klein & Associates, M.D., P.A.
Cumberland, Maryland, United States
Klein & Associates, M.D., P.A.
Hagerstown, Maryland, United States
NECCR PrimaCare Research
Fall River, Massachusetts, United States
Advanced Rheumatology, PC
Okemos, Michigan, United States
Saint Paul Rheumatology
Eagan, Minnesota, United States
AARA Clinical Research - Kansas City Physician Partners - North
Kansas City, Missouri, United States
Clinvest Headlands Llc
Springfield, Missouri, United States
Arthritis Consultants, Inc.
St Louis, Missouri, United States
Logan Health Research
Kalispell, Montana, United States
Physician Research Collaboration, LLC
Lincoln, Nebraska, United States
Albuquerque Center for Rheumatology
Albuquerque, New Mexico, United States
Inspire Santa Fe Medical Group
Santa Fe, New Mexico, United States
St. Lawrence Health System
Canton, New York, United States
Onsite Clinical Solutions, LLC - Brenner Ave
Salisbury, North Carolina, United States
Paramount Medical Research & Consulting, LLC
Middleburg Heights, Ohio, United States
RAO Research LLC
Oklahoma City, Oklahoma, United States
Essential Medical Research
Tulsa, Oklahoma, United States
Summit Headlands
Portland, Oregon, United States
Altoona Center For Clinical Research
Duncansville, Pennsylvania, United States
West Tennessee Research Institute
Jackson, Tennessee, United States
AARA Clinical Research - Murfreesboro Medical Clinic
Murfreesboro, Tennessee, United States
Tekton Research, LLC.
Austin, Texas, United States
Accurate Clinical Management, LLC
Baytown, Texas, United States
Precision Comprehensive Clinical Research Solutions - Colleyville
Colleyville, Texas, United States
Arthritis Care of Texas
Corpus Christi, Texas, United States
AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Fort Worth
Fort Worth, Texas, United States
Accurate Clinical Research, Inc
Houston, Texas, United States
Research Physicians Network, LLC
Houston, Texas, United States
AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving
Irving, Texas, United States
Biopharma Informatic, LLC
Katy, Texas, United States
West Texas Clinical Research
Lubbock, Texas, United States
Valley Arthritis Center
McAllen, Texas, United States
SouthWest Rheumatology Research, LLC
Mesquite, Texas, United States
Advanced Rheumatology of Houston - Woodlands
The Woodlands, Texas, United States
DM Clinical Research - TRA
Tomball, Texas, United States
Overlake Arthritis and Osteoporosis Center
Bellevue, Washington, United States
Arthritis Northwest, PLLC
Spokane, Washington, United States
Rheumatology & Pulmonary Clinic
Beckley, West Virginia, United States
Centro Reumatologico Caguas
Caguas, , Puerto Rico
Reuviva Research Center
Guaynabo, , Puerto Rico
GCM Medical Group, PSC - Hato Rey Site
San Juan, , Puerto Rico
Caribbean Medical Research Center
San Juan, , Puerto Rico
Mindful Medical Research
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I1F-MC-RHDB
Identifier Type: OTHER
Identifier Source: secondary_id
27241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.